Antiretroviral Therapy, Highly Active

"Antiretroviral Therapy, Highly Active" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Drug regimens, for patients with HIV INFECTIONS, that aggressively suppress HIV replication. The regimens usually involve administration of three or more different drugs including a protease inhibitor.

Descriptor ID	D023241
MeSH Number(s)	E02.319.310.075
Concept/Terms	Antiretroviral Therapy, Highly Active Antiretroviral Therapy, Highly Active Highly Active Antiretroviral Therapy HAART

Below are MeSH descriptors whose meaning is more general than "Antiretroviral Therapy, Highly Active".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Therapeutics [E02]
Drug Therapy [E02.319]
Drug Therapy, Combination [E02.319.310]
Antiretroviral Therapy, Highly Active [E02.319.310.075]

Below are MeSH descriptors whose meaning is related to "Antiretroviral Therapy, Highly Active".

Below are MeSH descriptors whose meaning is more specific than "Antiretroviral Therapy, Highly Active".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Antiretroviral Therapy, Highly Active" by people in this website by year, and whether "Antiretroviral Therapy, Highly Active" was a major or minor topic of these publications.

Bar chart showing 135 publications over 24 distinct years, with a maximum of 15 publications in 2005

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2000	1	0	1
2001	2	1	3
2002	1	4	5
2003	5	3	8
2004	4	5	9
2005	7	8	15
2006	6	3	9
2007	7	7	14
2008	3	2	5
2009	3	2	5
2010	3	5	8
2011	3	2	5
2012	3	4	7
2013	3	3	6
2014	4	6	10
2015	3	4	7
2016	1	2	3
2017	0	3	3
2018	0	3	3
2019	2	1	3
2020	1	1	2
2021	1	1	2
2022	0	1	1
2023	0	1	1

Below are the most recent publications written about "Antiretroviral Therapy, Highly Active" by people in Profiles.

Shikuma CM, Wojna V, De Gruttola V, Siriwardhana C, Souza SA, Rodriguez-Benitez RJ, Turner EH, Kallianpur K, Bolzenius J, Chow D, Matos M, Shiramizu B, Clements DM, Premeaux TA, Ndhlovu LC, Paul R. Impact of antiretroviral therapy intensification with C-C motif chemokine receptor 5 antagonist maraviroc on HIV-associated neurocognitive impairment. AIDS. 2023 11 01; 37(13):1987-1995.

View in: PubMed
Marques de Menezes EG, Deng X, Liu J, Bowler SA, Shikuma CM, Stone M, Hunt PW, Ndhlovu LC, Norris PJ. Plasma CD16+ Extracellular Vesicles Associate with Carotid Artery Intima-Media Thickness in HIV+ Adults on Combination Antiretroviral Therapy. mBio. 2022 06 28; 13(3):e0300521.

View in: PubMed
Tamargo JA, Hernandez-Boyer J, Teeman C, Martin HR, Huang Y, Johnson A, Campa A, Martinez SS, Li T, Rouster SD, Meeds HL, Sherman KE, Baum MK. Immune Activation: A Link Between Food Insecurity and Chronic Disease in People Living With Human Immunodeficiency Virus. J Infect Dis. 2021 12 15; 224(12):2043-2052.

View in: PubMed
Corley MJ, Sacdalan C, Pang APS, Chomchey N, Ratnaratorn N, Valcour V, Kroon E, Cho KS, Belden AC, Colby D, Robb M, Hsu D, Spudich S, Paul R, Vasan S, Ndhlovu LC. Abrupt and altered cell-type specific DNA methylation profiles in blood during acute HIV infection persists despite prompt initiation of ART. PLoS Pathog. 2021 08; 17(8):e1009785.

View in: PubMed
Myers K, Li T, Baum M, Ibanez G, Fennie K. The individual, interactive, and syndemic effect of substance use, depression, education, and ethnicity on retention in HIV care. Int J STD AIDS. 2021 02; 32(2):184-193.

View in: PubMed
Algarin AB, Sheehan DM, Varas-Diaz N, Fennie KP, Zhou Z, Spencer EC, Cook RL, Morano JP, Ibanez GE. Health Care-Specific Enacted HIV-Related Stigma's Association with Antiretroviral Therapy Adherence and Viral Suppression Among People Living with HIV in Florida. AIDS Patient Care STDS. 2020 07; 34(7):316-326.

View in: PubMed
Cunningham WE, Nance RM, Golin CE, Flynn P, Knight K, Beckwith CG, Kuo I, Spaulding A, Taxman FS, Altice F, Delaney JA, Crane HM, Springer SA. Self-reported antiretroviral therapy adherence and viral load in criminal justice-involved populations. BMC Infect Dis. 2019 Oct 29; 19(1):913.

View in: PubMed
Matheu M, Sunil T, Castro-Pe?a A, Spears CE, Smith CJ, Flores JM, Taylor BS. Lack of virologic suppression is associated with lower HIV-related disclosure stigma in people living with HIV. AIDS Care. 2020 08; 32(8):1001-1007.

View in: PubMed
Appiah LT, Sarfo FS, Huffman MD, Nguah SB, Stiles JK. Cardiovascular risk factors among Ghanaian patients with HIV: A cross-sectional study. Clin Cardiol. 2019 Dec; 42(12):1195-1201.

View in: PubMed
Pomerantz HS, Xu X, White J, Sunil TS, Deiss RG, Ganesan A, Agan BK, Okulicz JF. Association between quantitative varicella-zoster virus antibody levels and zoster reactivation in HIV-infected persons. AIDS Res Ther. 2018 12 11; 15(1):25.

View in: PubMed

People

Explore

Similar Concepts

Top Journals